Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,091 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Suboptimal Uptake, Retention, and Adherence of Daily Oral Prexposure Prophylaxis Among People With Opioid Use Disorder Receiving Hepatitis C Virus Treatment.
Brokus C, Kattakuzhy S, Gayle B, Narayanan S, Davis A, Cover A, Eyasu R, Ebah E, Ogbumbadiugha-Weekes O, Hoffmann J, Silk R, Stevens J, Mount J, Gannon C, Nussdorf L, Mathur P, Bijole P, Jones M, Kier R, Sternberg D, Greenblatt A, Weintraub E, Masur H, Kottilil S, Rosenthal E. Brokus C, et al. Among authors: narayanan s. Open Forum Infect Dis. 2021 Dec 29;9(3):ofab658. doi: 10.1093/ofid/ofab658. eCollection 2022 Mar. Open Forum Infect Dis. 2021. PMID: 35187191 Free PMC article.
Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use.
Spaderna M, Kattakuzhy S, Kang SJ, George N, Bijole P, Ebah E, Eyasu R, Ogbumbadiugha O, Silk R, Gannon C, Davis A, Cover A, Gayle B, Narayanan S, Pao M, Kottilil S, Rosenthal E. Spaderna M, et al. Among authors: narayanan s. Int J Drug Policy. 2023 Jan;111:103906. doi: 10.1016/j.drugpo.2022.103906. Epub 2022 Nov 13. Int J Drug Policy. 2023. PMID: 36384062 Free PMC article.
Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study.
Welker J, Pulido JD, Catanzaro AT, Malvestutto CD, Li Z, Cohen JB, Whitman ED, Byrne D, Giddings OK, Lake JE, Chua JV, Li E, Chen J, Zhou X, He K, Gates D, Kaur A, Chen J, Chou HY, Devenport M, Touomou R, Kottilil S, Liu Y, Zheng P; SAC-COVID Study Team. Welker J, et al. Lancet Infect Dis. 2022 May;22(5):611-621. doi: 10.1016/S1473-3099(22)00058-5. Epub 2022 Mar 11. Lancet Infect Dis. 2022. PMID: 35286843 Free PMC article. Clinical Trial.
A severe rash with pancytopenia.
Narayanan S, Traver EC, Markidan J. Narayanan S, et al. Lancet Infect Dis. 2022 Oct;22(10):1512. doi: 10.1016/S1473-3099(22)00453-4. Lancet Infect Dis. 2022. PMID: 36152667 No abstract available.
Solo With Cancer.
Narayanan S. Narayanan S. JAMA Intern Med. 2023 Mar 1;183(3):181-182. doi: 10.1001/jamainternmed.2022.6304. JAMA Intern Med. 2023. PMID: 36689206
2,091 results